A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
The COMMUNITY Center aims to study multiple chronic diseases by working with community-based partners and health care workers to produce sustainable interventions that will result in health equity.
January is a great month to donate blood since supplies usually run low after the holidays. And recent research from Columbia shows it's safe for donors.
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
Commonly used drugs that reduce joint inflammation in patients with rheumatoid arthritis also reduce vascular inflammation and cardiovascular risk, finds a new study from Columbia University.
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
Columbia's Clinical Innovation Lab, a hub that helps doctors develop new technologies to improve patient care, has already funded five projects. Yours could be next.